Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Berit Andersen

Showing results (151-160 of 161) with videos related to

Pageof 17
Sort By:
Cancer Control : Journal of the Moffitt Cancer Center|August 15, 2022
What can We Learn From High-Performing Screening Programs to Increase Bowel Cancer Screening Participation in Australia?Louisa Flander, Evelien Dekker, Berit Andersen, et al.
Gastrointestinal Endoscopy|June 22, 2024
Development of an algorithm combining blood-based biomarkers, fecal immunochemical test, and age for population-based colorectal cancer screeningMathias M Petersen, Jakob Kleif, Jason Liggett, et al.
Clinical Colorectal Cancer|March 6, 2023
Optimizing Screening for Colorectal Cancer: An Algorithm Combining Fecal Immunochemical Test, Blood-Based Cancer-Associated Proteins and Demographics to Reduce Colonoscopy BurdenMathias M Petersen, Jakob Kleif, Lars N Jørgensen, et al.
BMJ Open|January 25, 2025
How can cervical screening meet the needs of vulnerable women? A qualitative comparative study with stakeholder perspectives from seven European countriesRikke Buus Bøje, Marc Bardou, Keitly Mensah, et al.
BMJ Open|May 17, 2024
What are the barriers towards cervical cancer screening for vulnerable women? A qualitative comparative analysis of stakeholder perspectives in seven European countriesRikke Buus Bøje, Marc Bardou, Keitly Mensah, et al.
Open Forum Infectious Diseases|January 11, 2023
Persistent Symptoms and Sequelae After Severe Acute Respiratory Syndrome Coronavirus 2 Infection Not Requiring Hospitalization: Results From Testing Denmark, a Danish Cross-sectional SurveyMaarten van Wijhe, Kamille Fogh, Steen Ethelberg, et al.
British Journal of Cancer|October 10, 2024
Circulating tumour DNA and risk of recurrence in patients with asymptomatic versus symptomatic colorectal cancerNadia Øgaard, Sarah Østrup Jensen, Mai-Britt Worm Ørntoft, et al.
Microbiology Spectrum|December 15, 2021
Testing Denmark: a Danish Nationwide Surveillance Study of COVID-19Kamille Fogh, Jarl E Strange, Bibi F S S Scharff, et al.
BMC Infectious Diseases|February 11, 2022
Seroprevalence of SARS-CoV-2 antibodies in social housing areas in DenmarkKamille Fogh, Alexandra R R Eriksen, Rasmus B Hasselbalch, et al.
BMC Public Health|June 27, 2022
SARS-CoV-2 antibody prevalence among homeless people and shelter workers in Denmark: a nationwide cross-sectional studyAlexandra R Röthlin Eriksen, Kamille Fogh, Rasmus B Hasselbalch, et al.
Pageof 17

Showing results (151-160 of 161) with videos related to

Sort By:
Pageof 17
Cancer Control : Journal of the Moffitt Cancer Center|August 15, 2022
What can We Learn From High-Performing Screening Programs to Increase Bowel Cancer Screening Participation in Australia?Louisa Flander, Evelien Dekker, Berit Andersen, et al.
Gastrointestinal Endoscopy|June 22, 2024
Development of an algorithm combining blood-based biomarkers, fecal immunochemical test, and age for population-based colorectal cancer screeningMathias M Petersen, Jakob Kleif, Jason Liggett, et al.
Clinical Colorectal Cancer|March 6, 2023
Optimizing Screening for Colorectal Cancer: An Algorithm Combining Fecal Immunochemical Test, Blood-Based Cancer-Associated Proteins and Demographics to Reduce Colonoscopy BurdenMathias M Petersen, Jakob Kleif, Lars N Jørgensen, et al.
BMJ Open|January 25, 2025
How can cervical screening meet the needs of vulnerable women? A qualitative comparative study with stakeholder perspectives from seven European countriesRikke Buus Bøje, Marc Bardou, Keitly Mensah, et al.
BMJ Open|May 17, 2024
What are the barriers towards cervical cancer screening for vulnerable women? A qualitative comparative analysis of stakeholder perspectives in seven European countriesRikke Buus Bøje, Marc Bardou, Keitly Mensah, et al.
Open Forum Infectious Diseases|January 11, 2023
Persistent Symptoms and Sequelae After Severe Acute Respiratory Syndrome Coronavirus 2 Infection Not Requiring Hospitalization: Results From Testing Denmark, a Danish Cross-sectional SurveyMaarten van Wijhe, Kamille Fogh, Steen Ethelberg, et al.
British Journal of Cancer|October 10, 2024
Circulating tumour DNA and risk of recurrence in patients with asymptomatic versus symptomatic colorectal cancerNadia Øgaard, Sarah Østrup Jensen, Mai-Britt Worm Ørntoft, et al.
Microbiology Spectrum|December 15, 2021
Testing Denmark: a Danish Nationwide Surveillance Study of COVID-19Kamille Fogh, Jarl E Strange, Bibi F S S Scharff, et al.
BMC Infectious Diseases|February 11, 2022
Seroprevalence of SARS-CoV-2 antibodies in social housing areas in DenmarkKamille Fogh, Alexandra R R Eriksen, Rasmus B Hasselbalch, et al.
BMC Public Health|June 27, 2022
SARS-CoV-2 antibody prevalence among homeless people and shelter workers in Denmark: a nationwide cross-sectional studyAlexandra R Röthlin Eriksen, Kamille Fogh, Rasmus B Hasselbalch, et al.
Pageof 17